Search
for
Sort by
Research 121–150 of 1000+
- Female pattern hair loss
- Genetic basis of polycystic ovary syndrome
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Hair aging and anti-aging
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Hirsutism: A Clinico-investigative Study
- Assessment, diagnosis and treatment of a patient with hirsutism
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Study of Cutaneous Manifestations of Polycystic Ovarian Syndrome
- Clinical and Demographic Characteristics of Patients Diagnosed with Polycystic Ovary Syndrome: A Cross-Sectional Observational Study
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Developmental origin of polycystic ovary syndrome - a hypothesis
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Androgen excess is the key element in polycystic ovary syndrome
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Polycystic Ovary Syndrome
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Obesity and the Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment